Authors: Van Rompay, KKA McChesney, MB Aguirre, NL Schmidt, KA Bischofberger, N Marthas, ML

Citation: Kka. Van Rompay et al., Two low doses of tenofovir protect newborn macaques against oral simian immunodeficiency virus infection, J INFEC DIS, 184(4), 2001, pp. 429-438

Authors: Van Rompay, KKA Miller, MD Marthas, ML Margot, NA Dailey, PJ Canfield, DR Tarara, RP Cherrington, JM Aguirre, NL Bischofberger, N Pedersen, NC

Citation: Kka. Van Rompay et al., Prophylactic and therapeutic benefits of short-term 9-[2-(R)-(phosphonomethoxy)propyl]adenine (PMPA) administration to newborn macaques following oral inoculation with simian immunodeficiency virus with reduced susceptibility to PMPA, J VIROLOGY, 74(4), 2000, pp. 1767-1774

Authors: Van Rompay, KKA Marthas, ML

Citation: Kka. Van Rompay et Ml. Marthas, Nonhuman primate models for testing anti-HIV drugs, ANTIVIRALS AGAINST AIDS, 2000, pp. 295-320

Authors: Van Rompay, KKA Cherrington, JM Marthas, ML Lamy, PD Dailey, PJ Canfield, DR Tarara, RP Bischofberger, N Pedersen, NC

Citation: Kka. Van Rompay et al., 9-[2-(phosphonomethoxy)propyl]adenine (PMPA) therapy prolongs survival of infant macaques inoculated with simian immunodeficiency virus with reduced susceptibility to PMPA, ANTIM AG CH, 43(4), 1999, pp. 802-812

Authors: Van Rompay, KKA Dailey, PJ Tarara, RP Canfield, DR Aguirre, NL Cherrington, JM Lamy, PD Bischofberger, N Pedersen, NC Marthas, ML

Citation: Kka. Van Rompay et al., Early short-term 9-[2-(R)-(phosphonomethoxy)propyl]adenine treatment favorably alters the subsequent disease course in simian immunodeficiency virus-infected newborn rhesus macaques, J VIROLOGY, 73(4), 1999, pp. 2947-2955